Live Breaking News & Updates on Adria calatayud

Stay informed with the latest breaking news from Adria calatayud on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Adria calatayud and stay connected to the pulse of your community

Roche, Eli Lilly Alzheimer's Blood Test to Get Expedited FDA Review

By Adria Calatayud

Roche Holding said a blood test for earlier diagnosis of Alzheimer's disease it is developing together with Eli Lilly will get an expedited review by the U.S. Food and Drug...

Switzerland , Swiss , Eli-lilly , Adria-calatayud , Drug-administration , Roche-holding , Dow-jones ,

Novartis Says Early Addition of Cholesterol Drug Shows Positive Results in Trial

By Adria Calatayud

Novartis said new data from a late-stage clinical trial showed that early addition of its Leqvio drug reduced cholesterol in patients with atherosclerotic cardiovascular...

Switzerland , Swiss , Adria-calatayud , Novartis , Dow-jones ,

Eni Declares Final 2023 Dividend

By Adria Calatayud

Eni's board approved a final dividend for 2023 of 23 European cents a share, in line with what it paid for the first three quarters.

The Italian energy major confirmed...

Italy , Italian , Adria-calatayud , Dow-jones , Markets ,

Macquarie Consortium to Buy Digi's Spanish Fiber Network for Up to $813 Million

By Adria Calatayud

A consortium of Macquarie Capital, abrdn and Arjun Infrastructure Partners agreed to buy Digi Communications' Spanish fiber network for up to 750 million euros , the...

Spain , Romania , Romanian , Spanish , Adria-calatayud , Macquarie-capital , Arjun-infrastructure-partners , Digi-communication-spanish , Dow-jones ,

Novartis Shares Rise After Trial Data Supports New Filing for Cancer Drug

By Adria Calatayud

Novartis shares traded higher after the company said data from a late-stage trial in prostate cancer therapy Pluvicto support its plan to file for a label expansion in the...

Switzerland , Swiss , Adria-calatayud , Novartis , Dow-jones ,

UBS to Launch Buyback of Up to $2 Billion

By Adria Calatayud

UBS Group plans to launch a new share-buyback program of up to $2 billion.

The Swiss banking giant on Tuesday confirmed its expected share repurchases for 2024 will...

Switzerland , Swiss , Adria-calatayud , Dow-jones , Markets ,

Renault to Make Electric Vans for Venture With Volvo, CMA CGM at French Plant

By Adria Calatayud

Renault said it plans to build a new generation of electric vans for its Flexis joint venture with Swedish truck maker Volvo and shipping company CMA CGM at its plant in...

Sandouville , Haute-normandie , France , Sweden , Swedish , French , Adria-calatayud , Renault , Volvo , Cma-cgm , Dow-jones , Markets

UBS Restarts Buybacks With Program of Up to $2 Billion -- Update

By Adria Calatayud

UBS Group said it plans to repurchase up to $2 billion of its own stock, restarting share buybacks that were put on hold last year due to its acquisition of Credit Suisse....

Switzerland , Swiss , Adria-calatayud , Ubs-ag , Credit-suisse , Dow-jones ,

UBS Restates 2023 Net Profit After Cutting Estimate of Credit Suisse Gain

By Adria Calatayud

UBS Group said its net profit was lower than previously reported after reducing its fair-value estimate on the acquisition of Credit Suisse.

The Swiss banking giant said...

Switzerland , Swiss , Adria-calatayud , Credit-suisse , Dow-jones , Markets ,

UBS Gives CEO Ermotti Nearly $16 Million in 2023 Compensation

By Adria Calatayud

UBS Group said Chief Executive Sergio Ermotti's total compensation amounted to 14.4 million Swiss francs last year, a 14% increase compared with what his predecessor Ralph...

Switzerland , Swiss , Adria-calatayud , Sergio-ermotti , Ralph-hamers , Credit-suisse , Chief-executive-sergio-ermotti , Dow-jones , Markets ,